Polypharmacy in psychiatry: Unwanted side effects and inflammatory response system — a naturalistic study of 195 patients under treatment

2019 ◽  
Vol 29 ◽  
pp. S344-S345
Author(s):  
H.H. Stassen ◽  
S. Bachmann ◽  
R. Bridler ◽  
K. Cattapan ◽  
D. Herzig ◽  
...  
2001 ◽  
Vol 43 (2) ◽  
pp. 63-69
Author(s):  
Michael Maes ◽  
Dirk van West ◽  
Dirk Nuyten ◽  
Hugo Neels ◽  
Nathalie De Vos ◽  
...  

2005 ◽  
Vol 19 (4) ◽  
pp. e27-e28
Author(s):  
Maureen W Groer ◽  
Sandra P Thomas ◽  
Ginger Evans ◽  
Sally Helton

2002 ◽  
Vol 45 (1) ◽  
pp. 1-6 ◽  
Author(s):  
Jan Croonenberghs ◽  
Eugene Bosmans ◽  
Dirk Deboutte ◽  
Gunter Kenis ◽  
Michael Maes

2002 ◽  
Vol 14 (1) ◽  
pp. 1-10 ◽  
Author(s):  
J. Korf ◽  
H. C. Klein ◽  
J. Versijpt ◽  
J. A. den Boer ◽  
G. J. ter Horst

This paper summarizes the possible interrelation between peripheral and/or cerebral inflammation and depression. Often, depression is regarded as a consequence of life events, including disabling diseases. The question addressed here is whether activation of the inflammatory response system (IRS) can cause depression. Epidemiological studies suggest that depression can be precipitated by bacterial or viral infections. In depressed patients, peripheral markers of the IRS are often increased. There is some evidence that some forms of depression are caused by a viral infection of the limbic system. More consistent are the observations that depression in diseases with active cerebral inflammatory processes (e.g. multiple sclerosis, Alzheimer's disease) may concur. Direct evidence of a relation between depression and inflammation was found in post-mortem brain material of patients with a vascular depression. In both inflammatory brain diseases and in depression, a state-dependent increased hypothalamus–pituitary–adrenal axis activity is seen. Animals studies have shown that intact cerebral serotonin systems are required for the activation of the IRS following an endotoxin challenge and that long-term treatment with antidepressants may change such a response. Gender differences between the prevalence of depression and inflammatory diseases are similar, as more females are affected. We hypothesize that cerebral or peripheral activation of the IRS may contribute to the course of some antidepressant treatment-resistant depressions. Clinical trials combining antidepressants and drugs that reduce the activation of the IRS may provide evidence for such proposed depression subtypes.


Sign in / Sign up

Export Citation Format

Share Document